FL LYMPHOMA
Clinical trials for FL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FL LYMPHOMA trials appear
Sign up with your email to follow new studies for FL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested in fight against Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HH2853 in adults with advanced cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe and tolerable dose and to see if the drug shows any early signs of helping to …
Matched conditions: FL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug trial offers hope for Tough-to-Treat lymphomas
Disease control Recruiting nowThis early-stage study is testing an experimental drug called MDX2003 for people with several types of B-cell lymphoma that have come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It will…
Matched conditions: FL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC